Free shipping on all orders $250CAD or more within Canada.

5-AMINO-1MQ

  • HOME
  • |
  • 5-AMINO-1MQ

5-AMINO-1MQ

SKU 50AM2605A

5-Amino-1MQ is an experimental compound being studied for its possible relevance to weight management, body composition and age-related muscle health. It targets NNMT, an enzyme involved in how cells process energy and vitamin B3-related compounds.

Research is currently limited mainly to laboratory and animal studies. Human benefits, safety, dosage and long-term effects have not been established. This material is intended for laboratory research only, is not authorized by Health Canada for human therapeutic use, and is not intended for human or veterinary administration.



CA$89.99

In Stock

Choose a kit option to save more, or skip this and buy individually above.

Save 8%
2 Vials x 50mg
CA$165.00 CA$180.00
Save 13%
4 vials x 50mg
CA$315.00 CA$360.00
Save 20%
6 Vials x 50mg
CA$430.00 CA$540.00
Save 31%
10 Vials x 50mg
CA$620.00 CA$900.00
HPLC Purity Verified
Batch Documented
LC-MS Confirmation Available
2°C Storage

*LC-MS identity confirmation may be performed when analytical review indicates conflicting, atypical, or inconclusive results.

5-Amino-1MQ Research Overview

What is 5-Amino-1MQ?

5-Amino-1MQ, formally known as 5-amino-1-methylquinolinium iodide, is an experimental small molecule used in laboratory studies of nicotinamide N-methyltransferase, or NNMT.

Although 5-Amino-1MQ is frequently discussed alongside peptides, it is not a peptide. Peptides consist of amino acids connected by peptide bonds. 5-Amino-1MQ instead has a compact quinolinium-based chemical structure with no amino-acid sequence.

Researchers are interested in the compound because NNMT participates in two important areas of cellular chemistry:

  • Nicotinamide and NAD⁺ metabolism
  • Methyl-donor metabolism involving S-adenosyl-L-methionine, or SAM

Published research has examined 5-Amino-1MQ in enzyme assays, cultured cells and animal models. These investigations help researchers understand NNMT biology, but they do not establish that the compound is safe or effective for people.

Understanding NNMT in simple terms

NNMT is an enzyme found in several tissues, including the liver, adipose tissue, skeletal muscle, kidneys and other organs. Its biological role can differ depending on the tissue and experimental condition.

NNMT transfers a methyl group from SAM to nicotinamide:

Nicotinamide + SAM → 1-methylnicotinamide + SAH

Nicotinamide is a form of vitamin B3 and an important part of the cellular pathway used to regenerate NAD⁺. NAD⁺ is a naturally occurring coenzyme required for many cellular reactions involving energy transfer, metabolic regulation, DNA repair and cellular stress responses.

When NNMT methylates nicotinamide, it produces 1-methylnicotinamide, also called 1-MNA. This can reduce the amount of nicotinamide available to other pathways. At the same time, NNMT consumes SAM, one of the cell’s principal methyl-group donors.

NNMT does not directly destroy NAD⁺. Instead, it may influence how much nicotinamide remains available for NAD⁺ salvage and how cellular methyl donors are used.

How researchers investigate 5-Amino-1MQ

5-Amino-1MQ has been characterized as a substrate-site NNMT inhibitor. In laboratory terminology, an inhibitor is a compound that reduces the measured activity of an enzyme under defined experimental conditions.

The proposed research sequence is:

  1. 5-Amino-1MQ interacts with NNMT.
  2. NNMT-mediated methylation of nicotinamide decreases.
  3. Production of 1-methylnicotinamide may decline.
  4. More nicotinamide may remain available for other cellular pathways.
  5. NNMT-related consumption of SAM may also be reduced.
  6. These biochemical changes may influence downstream cellular activity.

A 2018 study reported an NNMT inhibitory concentration, or IC₅₀, of approximately 1.2 µM under the investigators’ assay conditions. IC₅₀ is a laboratory measurement describing the concentration associated with 50% inhibition in a particular assay. It is not a human dose and should not be converted into one.

Adipocyte and metabolic research

A 2014 study demonstrated that genetically reducing NNMT expression in the white adipose tissue and liver of mice affected SAM, NAD⁺ and cellular energy expenditure. This investigation helped establish NNMT as a metabolic research target, but it examined genetic NNMT reduction rather than administering 5-Amino-1MQ to humans. Kraus et al., 2014.

Researchers subsequently evaluated 5-Amino-1MQ directly. In differentiated adipocyte models, the compound produced concentration-dependent NNMT inhibition. The investigators also reported reductions in intracellular 1-MNA, changes in NAD⁺ availability and reduced lipid accumulation under their experimental conditions.

In diet-induced obese mice, an 11-day experiment reported changes in body weight, white-adipose-tissue mass and adipocyte size. These results were obtained in an animal model under controlled experimental conditions. They do not demonstrate weight-management effectiveness in people. Neelakantan et al., 2018.

Skeletal-muscle research

A 2019 study investigated NNMT inhibition in muscle stem cells obtained from aged experimental models. Researchers reported changes in muscle-cell proliferation, differentiation and fusion. The study also examined muscle regeneration following experimental injury in aged mice.

These observations have contributed to scientific interest in NNMT and age-related muscle biology. They do not demonstrate improved muscle growth, recovery or physical performance in people. Neelakantan et al., 2019.

A 2024 mouse study compared NNMT inhibition, exercise and a combination of both interventions. Researchers reported changes in grip strength and molecular pathways associated with muscle function. Because the study involved aged mice rather than people, the findings cannot establish a human exercise or muscle benefit. Dimet-Wiley et al., 2024.

Diet and microbiome research

Another mouse investigation examined NNMT inhibition alongside a reduced-calorie diet. Researchers evaluated adipose metabolites, body composition, liver-related measurements and intestinal microbiome patterns.

The compound and dietary intervention were studied together, meaning the reported results cannot necessarily be attributed to 5-Amino-1MQ alone. Microbiome findings from mice also cannot be assumed to occur in humans. Dimet-Wiley et al., 2022.

What might this research mean for humans?

NNMT is present in human tissues, making it a legitimate subject of human metabolic research. However, confirming that a pathway exists in humans is not the same as demonstrating that inhibiting it with 5-Amino-1MQ is safe or beneficial.

The current evidence supports studying questions such as:

  • How NNMT regulates nicotinamide handling
  • Whether NNMT activity affects intracellular NAD⁺ availability
  • How NNMT participates in methyl-donor metabolism
  • How changes in NNMT activity affect adipocyte development
  • Whether NNMT influences muscle-cell differentiation and aging
  • How NNMT activity differs across tissues and disease models

The evidence does not establish that consuming or administering 5-Amino-1MQ produces weight reduction, increased energy, improved insulin sensitivity, muscle preservation or anti-aging effects in people.

Important evidence limitations

The published research summarized here does not establish:

  • Human safety or tolerability
  • Human pharmacokinetics or bioavailability
  • An appropriate human route of administration
  • A safe or effective human dosage
  • Human weight-management effectiveness
  • Human muscle or exercise-performance benefits
  • Long-term toxicity
  • Reproductive or developmental safety
  • Genotoxicity or carcinogenicity
  • Interactions with medications, supplements or other compounds
  • Safety of oral, injectable or other forms of human administration

Animal and cell-culture results frequently differ from human clinical outcomes. Experimental exposure levels should not be converted into human-use instructions.

Research status

5-Amino-1MQ remains an investigational research compound. It is not authorized by Health Canada as a therapeutic product and has no Health Canada-approved indication or established human dosage.

This material is supplied exclusively for controlled laboratory research. It is not intended to diagnose, treat, cure, prevent or reduce the risk of any disease or medical condition.

Not for human consumption, veterinary use, clinical use, compounding or administration to humans or animals.

5-Amino-1MQ Iodide — General Product Specifications

Chemical Identification

Product name: 5-Amino-1MQ Iodide

Full chemical name: 5-Amino-1-methylquinolin-1-ium iodide

Alternative names: 5-Amino-1MQ, 5A-1MQ and NNMTi

Chemical category: Quinolinium-derived small molecule

Research classification: Nicotinamide N-methyltransferase inhibitor

Molecular form: Iodide salt

CAS number: 42464-96-0

PubChem CID: 66522933

Primary research target: Nicotinamide N-methyltransferase

Target abbreviation: NNMT

5-Amino-1MQ is a small organic molecule rather than a peptide. It does not contain an amino-acid sequence, amino-acid residues or peptide bonds.

Molecular Information

5-Amino-1MQ contains a quinolinium structure composed of two fused aromatic rings. An amino group, represented as –NH₂, is attached at the fifth position. A methyl group, represented as –CH₃, is bonded to the nitrogen within the quinolinium ring.

The organic portion of the molecule carries a positive charge. In the iodide form, this positive charge is balanced by a negatively charged iodide ion, producing an electrically neutral salt overall.

Organic cation formula: C₁₀H₁₁N₂⁺

Complete iodide-salt formula: C₁₀H₁₁IN₂

Plain-text molecular formula: C10H11IN2

Organic cation molecular weight: 159.21 g/mol

Complete iodide-salt molecular weight: 286.11 g/mol

Calculated exact salt mass: 285.9967 Da

Canonical SMILES: C[N+]1=CC=CC2=C(C=CC=C12)N.[I-]

InChIKey: JPEZFBFIRRAFNR-UHFFFAOYSA-N

Chemical identifiers are consistent with the PubChem record for 5-Amino-1MQ iodide.

General Molecular Composition

The complete iodide salt contains:

  • 10 carbon atoms
  • 11 hydrogen atoms
  • 2 nitrogen atoms
  • 1 iodine atom

Its calculated elemental composition is approximately:

  • Carbon: 41.98%
  • Hydrogen: 3.88%
  • Nitrogen: 9.79%
  • Iodine: 44.35%

The organic 5-amino-1-methylquinolinium component represents approximately 55.64% of the theoretical molecular mass. The iodide counterion represents approximately 44.36%.

These values are theoretical calculations based on the molecular formula. They do not represent the analytical result of a particular batch or product quantity.

General Physical Characteristics

5-Amino-1MQ iodide is generally supplied as a solid research material. Its appearance may range from orange or reddish-brown to darker brown depending on the manufacturing process, physical form and storage conditions.

Appearance alone cannot establish chemical identity, purity or concentration. Colour and texture may vary between production batches and suppliers.

The material should not be described as lyophilized unless freeze-drying has been confirmed as part of the manufacturing process.

General Solubility Information

Reference suppliers report that 5-Amino-1MQ iodide is soluble in DMSO. Actual solubility can depend on:

  • Solvent composition
  • Concentration
  • Temperature
  • pH
  • Mixing conditions
  • Material purity
  • Salt form

Researchers should determine solvent compatibility and solution stability for their specific laboratory method. General solubility information should not be interpreted as preparation or administration instructions.

General Analytical Characterization

Several analytical methods may be used to evaluate 5-Amino-1MQ iodide.

High-performance liquid chromatography may be used to examine chromatographic purity and compare retention behaviour with a qualified reference standard.

Mass spectrometry may provide additional evidence for the identity of the organic 5-amino-1-methylquinolinium component. In positive-ion analysis, the theoretical organic cation may be observed near m/z 159.092, depending on the instrument and analytical method.

Other analytical techniques may include:

  • High-resolution mass spectrometry
  • Nuclear magnetic resonance spectroscopy
  • Iodide counterion confirmation
  • Elemental analysis
  • Water-content analysis
  • Residual-solvent analysis
  • Quantitative assay against a qualified reference standard

Analytical results are batch-specific and should be reviewed separately in the documentation associated with the applicable material.

General Storage and Handling

Keep the material:

  • In a tightly sealed container
  • In a dry environment
  • Protected from moisture
  • Protected from direct light
  • Protected from repeated temperature changes
  • Under the storage conditions specified by the manufacturer or applicable product documentation

Chemical stability may be affected by temperature, moisture, light, solvent exposure and repeated opening of the container.

Appropriate personal protective equipment and established laboratory handling procedures should be used. Researchers should consult the applicable Safety Data Sheet before handling the material.

Research Classification and Restrictions

5-Amino-1MQ iodide is an experimental research compound. It is not represented as a drug, natural health product, dietary supplement, food, cosmetic, diagnostic agent or veterinary product.

Published research involving 5-Amino-1MQ is primarily preclinical. Available findings do not establish human safety, effectiveness, dosage or an appropriate route of administration.

This material is not intended for:

  • Human consumption
  • Human or veterinary administration
  • Therapeutic use
  • Diagnostic use
  • Compounding
  • Food or beverage use
  • Cosmetic application
  • Household use

For controlled laboratory research only. Not for human or veterinary use.

TESTING METHODOLOGY

Selected batches are submitted to independent analytical laboratories for testing. HPLC analysis is used to assess chromatographic purity and evaluate the sample profile against applicable reference data. When additional structural information is required, LC-MS may be used to support molecular-mass and compound-identity assessment.

OUR ANALYTICAL VERIFICATION PROGRAM

  • Primary Analysis: HPLC purity determination and chromatographic profile review
  • Additional Analysis: LC-MS molecular-mass confirmation when applicable
  • Documentation: Batch-specific analytical reports and unique batch identification

*Traceability: Recorded supplier, testing, receipt and storage information

Each tested batch supplied by Vanguard Compound Research is assigned a unique batch number and maintained under documented quality-control and traceability procedures. Available analytical reports relate specifically to the batch and testing methods identified in the corresponding documentation.

SHIPPING & FULFILLMENT

FULFILLMENT INFORMATION
Ships from Canada

All orders ship from within Canada.

Batch Documentation Available

Batch records and analytical documentation may be provided for qualifying products.

Secure Packaging

Products are packaged securely to ensure safe delivery.

Tracking Provided

Tracking information is provided for every shipment.

Temperature-Conscious Handling

Frozen or ambient-safe packaging used as appropriate.

All Vanguard Compound Research orders are shipped directly from within Canada, ensuring efficient delivery, reliable service, and consistent quality-control from fulfillment to arrival.

Canadian Researchers Benefit From:

  • Domestic shipping with no customs delays
  • Batch-specific third-party laboratory testing
  • Full lot number traceability on every product
  • Access to batch-specific Certificates of Analysis (COAs)
  • Dedicated customer support

Canada-Wide Fulfillment:

  • Orders processed Monday through Friday
  • Shipments dispatched throughout Canada
  • Discreet and secure packaging
  • Tracking provided with every shipment

Batch Documentation & Testing

Products are maintained under documented quality-control procedures to help ensure quality, consistency, and transparency.

  • HPLC purity analysis
  • Reference-standard comparison
  • Additional verification procedures (e.g. LC-MS confirmation) may be performed where warranted
  • Lot number traceability

Each product is assigned a unique lot number, allowing researchers to match their item directly to its corresponding Certificate of Analysis (COA).

Analytical Documentation

Supporting analytical documentation may be available for qualifying products, including batch-specific quality records and testing information.

Documentation may include:
  • Batch Number
  • Analytical Results
  • Traceability Records
  • Storage Information

RELATED PRODUCTS